Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 5/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carabersat SCHEMBL29373163 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL9287969 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL27418709 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3308650 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3301553 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3301548 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3300409 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL27394684 | 1.00 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL5317948 | 0.99 | ABCC9 (0.64) | ABCC9 | |
| Carabersat SCHEMBL5317945 | 0.99 | ABCC9 (0.64) | ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3183346-B1 | CHANNEL MODULATORS | AUCKLAND UNISERVICES LTD (NZ) | 2024-10-23 | — | — | EP | claimed |
| US-10272077-B2 | Piperidinone carboxamide azaindane CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2019-04-30 | — | — | US | claimed |
| US-20180092900-A1 | PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2018-04-05 | — | — | US | claimed |
| EP-3087062-A1 | PRODRUG COMPOUNDS | Proximagen Limited (GB) | 2016-11-02 | — | — | EP | claimed |
| US-20160016929-A1 | PRO-DRUG COMPOUNDS | PROXIMAGEN LIMITED | 2016-01-21 | — | — | US | claimed |
| EP-2970226-A1 | PRO-DRUG COMPOUNDS | Proximagen Limited (GB) | 2016-01-20 | — | — | EP | claimed |
| WO-2015097461-A1 | PRODRUG COMPOUNDS | PROXIMAGEN LIMITED (GB) | 2015-07-02 | — | — | WO | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| WO-2014140510-A1 | PRO-DRUG COMPOUNDS | PROXIMAGEN LIMITED (GB) | 2014-09-18 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| US-6492415-B2 | ESPECIALLY FOR TRIGEMINAL NEURALGIA AND NEUROPATHIC PAIN. | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-12-10 | — | — | US | claimed |
| EP-0587645-B1 | BENZO- AND PYRIDOPYRAN DERIVATIVES HAVING ANXIOLYTIC AND ANTI-CONVULSANT ACTIVITY | SMITHKLINE BEECHAM PLC (GB) | 2002-02-27 | — | — | EP | claimed |
| US-20020010209-A1 | Use of benzopyranols to treat neurological disorders | PARSONS ANDREW (GB) | 2002-01-24 | — | — | US | claimed |
| EP-1108718-A2 | Trans-6-Acetyl-4S-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3R-ol | SMITHKLINE BEECHAM PLC (GB) | 2001-06-20 | — | — | EP | claimed |
| US-5889044-A | Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-03-30 | — | — | US | claimed |
| US-5624954-A | Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-04-29 | — | — | US | claimed |
| WO-1994012173-A1 | BENZOPYRON ANALOGUES FOR THE TREATMENT OF ANXIETY, MANIA, DEPRESSION OR WITHDRAWAL SYMPTOMS | SMITHKLINE BEECHAM PLC (GB) | 1994-06-09 | — | — | WO | claimed |
| EP-0126311-B1 | BENZOPYRAN DERIVATIVES. | BEECHAM GROUP PLC (GB) | 1989-09-13 | — | — | EP | claimed |
| US-4571406-A | Anti-hypertensive chromans and chromenes | BEECHAM GROUP P.L.C. (GB) | 1986-02-18 | — | — | US | claimed |
| EP-0126311-A2 | Benzopyran derivatives. | BEECHAM GROUP PLC (GB) | 1984-11-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180092900-A1 | PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS | CALCRL, CALCR, CNR2 | ABCC9 1308/4885 |
| US-20020010209-A1 | Use of benzopyranols to treat neurological disorders | TARDBP, HTT, GRIN3A | ABCC9 3301/4885 |
| US-20160016929-A1 | PRO-DRUG COMPOUNDS | H1-0, ZYX, FURIN | ABCC9 103/4885 |
| US-10272077-B2 | Piperidinone carboxamide azaindane CGRP receptor antagonists | CALCRL, CALCR, CNR2 | ABCC9 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.